Literature DB >> 26065548

Leg ulcer as a manifestation of eosinophilic vasculitis in a patient with hepatitis C virus infection, medicated with pegylated interferon/ribavirin.

Cristina Resende1, Teresa Pereira1, Filipa Ventura1, Celeste Brito1.   

Abstract

Cryoglobulinaemic vasculitis is a complication of hepatitis C virus (HCV) infection, responding to treatment with pegylated interferon (peg-IFN)/ribavirin (RIB), but vasculitis may first appear after treatment with peg-IFN/RIB. A 35-year-old man with HCV infection presented to our department with a 2-month history of a 3.3 × 3 cm ulcer localised on the right shin, with a regular border, on a violaceous base. Histopathological examination revealed a leucocytoclastic vasculitis, rich in eosinophils. The patient had been treated with peg-IFN/RIB 10 months prior and treatment was discontinued after 2 months because of the appearance of arthralgias and neuropathy. Laboratory investigations revealed positive cryoglobulins, elevation of rheumatoid factor and reduction of C4 after treatment with peg-IFN/RIB. Dressings with a hydrocellular foam were placed and after 2 months the ulcer resolved. We presented this case because of the rarity of development of a cryoglobulinaemic vasculitis in a patient with HCV infection, previously treated with peg-IFN/RIB. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26065548      PMCID: PMC4480100          DOI: 10.1136/bcr-2015-209377

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.

Authors:  Esra Adişen; Murat Dizbay; Kenan Hizel; Nilsel Ilter
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Jan-Feb       Impact factor: 2.545

Review 2.  Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

Authors:  Maurizio Pietrogrande; Salvatore De Vita; Anna Linda Zignego; Pietro Pioltelli; Domenico Sansonno; Salvatore Sollima; Fabiola Atzeni; Francesco Saccardo; Luca Quartuccio; Savino Bruno; Raffaele Bruno; Mauro Campanini; Marco Candela; Laura Castelnovo; Armando Gabrielli; Giovan Battista Gaeta; Piero Marson; Maria Teresa Mascia; Cesare Mazzaro; Francesco Mazzotta; Pierluigi Meroni; Carlomaurizio Montecucco; Elena Ossi; Felice Piccinino; Daniele Prati; Massimo Puoti; Piersandro Riboldi; Agostino Riva; Dario Roccatello; Evangelista Sagnelli; Patrizia Scaini; Salvatore Scarpato; Renato Sinico; Gloria Taliani; Antonio Tavoni; Eleonora Bonacci; Piero Renoldi; Davide Filippini; Piercarlo Sarzi-Puttini; Clodoveo Ferri; Giuseppe Monti; Massimo Galli
Journal:  Autoimmun Rev       Date:  2011-02-15       Impact factor: 9.754

3.  Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.

Authors:  F Marrache; Y Consigny; M P Ripault; D Cazals-Hatem; M Martinot; N Boyer; C Degott; D Valla; P Marcellin
Journal:  J Viral Hepat       Date:  2005-07       Impact factor: 3.728

4.  Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.

Authors:  Dominique Batisse; Marina Karmochkine; Christian Jacquot; Michel D Kazatchkine; Laurence Weiss
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 2.566

Review 5.  Hepatitis C virus-induced vasculitis: therapeutic options.

Authors:  Patrice Cacoub; Benjamin Terrier; David Saadoun
Journal:  Ann Rheum Dis       Date:  2013-08-06       Impact factor: 19.103

6.  Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.

Authors:  Peter J Ruane; Dani Ain; Richard Stryker; Raymond Meshrekey; Mina Soliman; Peter R Wolfe; Joseph Riad; Sameh Mikhail; Kathryn Kersey; Deyuan Jiang; Benedetta Massetto; Brian Doehle; Brian J Kirby; Steven J Knox; John G McHutchison; William T Symonds
Journal:  J Hepatol       Date:  2014-11-05       Impact factor: 25.083

Review 7.  Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature.

Authors:  Wilke Beuthien; Hans-Ullrich Mellinghoff; Johannes von Kempis
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 3.650

8.  A case of cutaneous vasculitis with underlying hepatitis C and cryoglobulinaemia.

Authors:  Cheryl Groves; Clare Devereux; Clifford McMillan
Journal:  Ulster Med J       Date:  2008-01

Review 9.  Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives.

Authors:  Elisabetta Degasperi; Alessio Aghemo
Journal:  Hepat Med       Date:  2014-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.